Hannover Re (HNR1) PT Set at €121.00 by Independent Research

Independent Research set a €121.00 ($144.05) target price on Hannover Re (FRA:HNR1) in a research note released on Monday, May 7th. The brokerage currently has a neutral rating on the stock.

Several other analysts have also issued reports on the stock. Barclays set a €105.40 ($125.48) price target on shares of Hannover Re and gave the company a sell rating in a research report on Thursday, February 1st. Credit Suisse Group set a €120.00 ($142.86) price objective on shares of Hannover Re and gave the company a buy rating in a research note on Thursday, February 8th. Goldman Sachs set a €111.00 ($132.14) price objective on shares of Hannover Re and gave the company a neutral rating in a research note on Thursday, February 8th. Commerzbank set a €112.00 ($133.33) price target on shares of Hannover Re and gave the stock a neutral rating in a research note on Thursday, February 8th. Finally, DZ Bank reissued a buy rating on shares of Hannover Re in a research note on Wednesday, March 14th. Five equities research analysts have rated the stock with a sell rating, seventeen have assigned a hold rating and three have assigned a buy rating to the company. Hannover Re presently has an average rating of Hold and an average price target of €110.78 ($131.88).

Hannover Re stock opened at €113.70 ($135.36) on Monday. Hannover Re has a fifty-two week low of €94.75 ($112.80) and a fifty-two week high of €116.37 ($138.54).

About Hannover Re

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.

Analyst Recommendations for Hannover Re (FRA:HNR1)

Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply